The Durable Effect of Pyrotinib Plus Trastuzumab and Chemotherapy in HER2-Positive Gastric Cancer With Brain Metastases: A Case Report and Literature Review

Gastric cancer (GC) is a disease with macromolecular phenotypic heterogeneity and poor prognosis, especially for metastatic GC (mGC). Chemotherapy is the first choice for second-line treatment. However, the benefits of second-line chemotherapy are limited, so there is an urgent need for new treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinwei, Zeng, Yun, Zhang, Junling, Huang, Mengli, Yin, Bijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304692/
https://www.ncbi.nlm.nih.gov/pubmed/35875121
http://dx.doi.org/10.3389/fonc.2022.940263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304692/
https://www.ncbi.nlm.nih.gov/pubmed/35875121
http://dx.doi.org/10.3389/fonc.2022.940263

Ejemplares similares